Spegra (Dolutegravir +Emtricitabine+TAF)

Dolutegravir +Emtricitabine+TAF
Contact us for more information
Цвет:
Вариант:
Wishlist Compare
Emcure Pharmaceuticals Ltd

Spegra (Dolutegravir +Emtricitabine+TAF)

ManufacturerEmcure Pharmaceuticals LtdBrand nameSpegraActive substanceDolutegravir+Emtricitabine+TAFStrength50mg+200mg+25mgCategoryHIVManufacturerEmcure Pharmaceuticals Ltd

Description  of  Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg)

Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) tablets Is a combination of dolutegravir,emcitarabine,temnofovir alafenamide . Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) belongs to the calss of agent known as anti-retroviral agents. Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) tablet is used to treat HIV type I infection. Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) tablet preferred for HIV infection, it is non-curable and non-preventable. But the growth of HIV virus can be suppressed and leads to elevate immune cells .

 SIDE EFFECTS  of  Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg)

 Nausea
• Fatigue
• Abdominal pain
• Vomitting
• Anemieadeacresed platlet count
• Increased serum creatinin
• Diarrhea
• Upper respiratory tract infection

PRECAUTION  of  Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg)

Liver toxicity
Monitor the liver function test Maintain the hepatic enzymes In severe condition, stop the treatment
Bone defects
Loss of calcium levels occur causes osteomalacia while on treatment Prevent the problem by providing vitamin D supplements.
Fat redistribution
Discontinue the Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) tablets
QT prolongation
QT prolongation reduced by avoiding the concomitant use of Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) with drugs which may extends the QT intervals.

CONTRAINDICATION of  Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg)

Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) is contraindicated to patients who are concomitantly received elbasvir & grazoprevir. Hypersensitivity reactions of Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) are produced due to patients is contraindicated to the component of Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg).

 


STORAGE  of  Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg)

 

Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) container should be kept at temperature below 30oc Store the drug container away from heat, moisture & light.

MISSED DOSE of  Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg)

Please consult the doctor. Maintain the regular dosing schedule Avoid the missed dose if possible Do not self medicate the Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) tablets. Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) is a three drug mixed dose regimen, caution should be taken during therapy using with Spegra (Dolutegravir 50mg +Emtricitabine 200mg+Tenofovir Alafenamide 25mg) tablets.

Brand name:
Spegra
Active substance:
Dolutegravir+Emtricitabine+TAF
Strength:
50mg+200mg+25mg
Category:
HIV
Manufacturer:
Emcure Pharmaceuticals Ltd
Packaging:
30 Tablet
Product form:
Tablet

No reviews found

Write feedback
Worldwide delivery

Our company ships from India to all countries of the world.

Genuine and Authentic products

All products supplied from the manufacturer of WHO : GMP certified facilities and ISO Certified facilitates

Economical and Affordable prices

All the products are supplying from manufacturing companies of India